Nowadays, several proteomic methods are available in the market, such as specific IgE micro– and macroarray tests, which are extremely useful for evaluating hundreds of native or recombinant molecular components in patients with primary immunodeficiency (PID) [13,14] or AD [15]. Here, IGHE is linked to Alzheimer disease.